ATE159022T1 - Ecteinascidine 736 und 722 - Google Patents

Ecteinascidine 736 und 722

Info

Publication number
ATE159022T1
ATE159022T1 AT92904206T AT92904206T ATE159022T1 AT E159022 T1 ATE159022 T1 AT E159022T1 AT 92904206 T AT92904206 T AT 92904206T AT 92904206 T AT92904206 T AT 92904206T AT E159022 T1 ATE159022 T1 AT E159022T1
Authority
AT
Austria
Prior art keywords
tetrahydro
ecteinascidine
ecteinascidins
isoquinolines
carboline
Prior art date
Application number
AT92904206T
Other languages
English (en)
Inventor
Kenneth Rinehart
Ryuichi Sakai
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Application granted granted Critical
Publication of ATE159022T1 publication Critical patent/ATE159022T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92904206T 1990-11-30 1991-11-27 Ecteinascidine 736 und 722 ATE159022T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/620,427 US5149804A (en) 1990-11-30 1990-11-30 Ecteinascidins 736 and 722

Publications (1)

Publication Number Publication Date
ATE159022T1 true ATE159022T1 (de) 1997-10-15

Family

ID=24485894

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92904206T ATE159022T1 (de) 1990-11-30 1991-11-27 Ecteinascidine 736 und 722

Country Status (10)

Country Link
US (1) US5149804A (de)
EP (1) EP0559838B1 (de)
JP (1) JP3098029B2 (de)
AT (1) ATE159022T1 (de)
AU (1) AU650829B2 (de)
DE (1) DE69127905T2 (de)
DK (1) DK0559838T3 (de)
ES (1) ES2111631T3 (de)
GR (1) GR3025837T3 (de)
WO (1) WO1992009607A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478932A (en) * 1993-12-02 1995-12-26 The Board Of Trustees Of The University Of Illinois Ecteinascidins
US20040059112A1 (en) * 1994-02-18 2004-03-25 Rinehart Kenneth L. Ecteinascidins
US5721362A (en) * 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds
CA2301693A1 (en) * 1997-09-19 1999-04-01 Klaus Unsicker Cytokines having neurotrophic activity
BR9909488B1 (pt) * 1998-04-06 2011-02-08 ecteinascidinas semi-sintéticas e composição farmacêutica.
CA2331593C (en) * 1998-05-11 2008-08-05 Pharma Mar, S.A. Metabolites of ecteinascidin 743
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
AR035842A1 (es) * 1999-05-14 2004-07-21 Pharma Mar Sa Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo
US7919493B2 (en) * 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
WO2001077115A1 (en) * 2000-04-12 2001-10-18 Pharma Mar, S.A. Antitumoral ecteinascidin derivatives
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
US7420051B2 (en) * 2000-05-15 2008-09-02 Pharma Mar, S.A. Synthetic process for the manufacture of an ecteinaschidin compound
BR0115162A (pt) * 2000-11-06 2003-10-21 Pharma Mar Sa Tratamentos antitumorais eficazes
GB0117402D0 (en) * 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) * 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
GB0202544D0 (en) * 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment
GB0324201D0 (en) * 2003-10-15 2003-11-19 Pharma Mar Sau Improved antitumoral combinations
HRP20080598T3 (en) * 2003-11-13 2009-01-31 Pharma Mar Combination of et-743 with 5-fluorouracil pro-drugs for the treatment of cancer
GB0326486D0 (en) * 2003-11-14 2003-12-17 Pharma Mar Sau Combination treatment
AU2004291037A1 (en) * 2003-11-14 2005-06-02 Pharma Mar, S.A. Combination therapy comprising the use of ET-743 and paclitaxel for treating cancer
WO2006005602A2 (en) * 2004-07-09 2006-01-19 Pharma Mar, S.A. Use of ecteinascidin in the treatment of cancer in patients with low level of brca1
AU2005288696A1 (en) * 2004-09-28 2006-04-06 Pharma Mar S.A., Sociedad Unipersonal Ecteinascidin compounds as anti -inflammatory agents
EP1827500B1 (de) * 2004-10-26 2009-05-06 Pharma Mar S.A., Sociedad Unipersonal Pegyliertes liposomales doxorubicin in kombination mit ecteinescidin 743
ATE368461T1 (de) 2004-10-29 2007-08-15 Pharma Mar Sa Zusammensetzungen enthaltend ecteinascidin und einen disaccharide
GB0522082D0 (en) * 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
US20100267732A1 (en) * 2007-10-19 2010-10-21 Pharma Mar, S.A. Prognostic Molecular Markers for ET-743 Treatment
RS54648B1 (sr) 2010-11-12 2016-08-31 Pharma Mar S.A. Kombinovana terapija sa antitumorskim alkaloidom
KR102491180B1 (ko) 2017-04-27 2023-01-20 파르마 마르 에스.에이. 항종양 화합물
PE20252386A1 (es) 2019-11-21 2025-10-10 Pharma Mar Sa Metodo de tratamiento del cancer de pulmon de celulas pequenas con formulaciones de lurbinectedina
CN115427081B (zh) 2020-04-21 2025-12-09 法马马有限公司 药物抗体共轭物

Also Published As

Publication number Publication date
US5149804A (en) 1992-09-22
EP0559838B1 (de) 1997-10-08
JP3098029B2 (ja) 2000-10-10
DK0559838T3 (da) 1998-05-18
GR3025837T3 (en) 1998-04-30
ES2111631T3 (es) 1998-03-16
EP0559838A1 (de) 1993-09-15
WO1992009607A1 (en) 1992-06-11
DE69127905D1 (de) 1997-11-13
AU9176491A (en) 1992-06-25
AU650829B2 (en) 1994-06-30
EP0559838A4 (en) 1994-06-29
DE69127905T2 (de) 1998-05-28
JPH06503579A (ja) 1994-04-21

Similar Documents

Publication Publication Date Title
DE69127905D1 (de) Ecteinascidine 736 und 722
IT1083903B (it) Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche
DE59008361D1 (de) Polycyclische 3-Aryl-pyrrolidin-2,4,-dion-Derivate.
FI885726A0 (fi) Ecteinaskidiner 729, 743, 745, 759a, 759b och 770.
IT1145403B (it) Derivati di 1,2-diidro-2-osso-4-fenil-3-chinolin-carbonitrile dotati di proprieta' anti-infiammatorie
FR2375234A1 (fr) 1,2-dihydro-3h-pyrrolo(1,2-a)pyrrole-1-carboxylates et leur obtention
FI905399A0 (fi) Foerfarande och anordning foer framkallning av kantspaenning i vindruta i boejningsugn foer vindrutor.
DE3765808D1 (de) Heterocyclische tetrahydro-3,4-diamin-n-n'-platin-komplexe.
IT8819222A0 (it) 5 ossi derivati del tetraidrofurano.
FI924344A0 (fi) Kompositioner omfattande ett cytotoxiskt medel och permeabilitetpotentierande medel.
FI925718A0 (fi) Heterocykliska foereningar och deras framstaellning och anvaendning
FI900286A7 (fi) Foerfarande och anordning foer flishuggning av trae.
SE418192B (sv) Extraktionsbestendiga polyolefinstabilisatorer och motsvarande polyolefinkompositioner
FI911219A0 (fi) Ny pentapeptid och foerfarande foer framstaellning av densamma.
FR2669631B1 (fr) Nouveaux derives de l'oxazolidine, leur preparation et leur emploi.
BE856647A (fr) Pyrrolo (3,2-f)quinazoline-1,3-diamines et leur preparation
FI912269A0 (fi) 3'-deamino - 4'deoxi - 4'-amino- 8 -fluorantracykliner och framstaellningsfoerfaranden foer dessa.
ES2101531T3 (es) Derivados de benzo(f)quinoxalinadiona, su preparacion y su utilizacion en medicamentos.
FR2298545A1 (fr) Nouveaux derives de la triazine et leur emploi comme stabilisants aux uv
FI910012A0 (fi) Styrfoerfarande och styrsats foer daempning av resonanssvaengningar i en parallellsvaengkrets foer en pulsvaexelriktare i en stroemmellankretsomformare.
ES2073915T3 (es) 6,9-bis(amino sustituido)benzo g)ftalazin-5,10-diona como agentes antitumorales.
FI910839A0 (fi) Saett och anordning foer driftoevervakning av en roterande vaermevaexlare.
FI924723L (fi) Foerfarande och anordning foer fraemjande av utvaexling av gas i en slutenbehaollare
BE855296A (fr) Nouveaux derives de la vincamine, leur preparation et les compositions therapeutiques les contenant
BE870873Q (fr) Les alkyl-2,3-dihydro-3-(1'-hydroxylakylidene)-2-oxo-5-alkylfurane-4-carboxylates et leur emploi comme arommatisants

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time